Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

Palma, D.; Olson, R.; Harrow, S.; Gaede, S.; Louie, A.; Haasbeek, C.; Mulroy, L.; Lock, M.; Rodrigues, G.; Yaremko, B.; Schellenberg, D.; Ahmad, B.; Senthi, S.; Swaminath, A.; Kopek, N.; Liu, Mengxing; Moore, K.; Currie, S.; Schlijper, R.; Bauman, G.; Labe, J.; Qu, M.; Warner, A.; Senan, S.

doi:10.1200/JCO.20.00818

Public

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

Shared by NobleBlocks on Sep 1, 2020 • 12:00 AM UTC

Authors:

David A. Palma

Robert Olson

Stephen Harrow

Abstract

PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test this paradigm are lacking. METHODS We enrolled patients with a...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!